0 likes | 12 Views
This report presents a strategic analysis of Finland Artificial Intelligence (AI) in Healthcare Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about Finland Artificial Intelligence (AI) in Healthcare Market, and offers unmatched value, accuracy, and expert insights.
E N D
Sample Report Finland Artificial Intelligence (AI) in Healthcare Market Analysis July 2024
This report presents a strategic analysis of Finland Artificial Intelligence (AI) in Healthcare Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about Finland Artificial Intelligence (AI) in Healthcare Market, and offers unmatched value, accuracy, and expert insights.
Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2023 Forecast Period 2024-2030 Market Overview, Size & Forecasting, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Currency Conversion 1 Euro = 1.08 USD Research Approach Secondary Research (90%), Primary Research (10%) 3 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Table of Content CONTENT PG. NO. 6-14 1. Market Overview 1.1 Artificial Intelligence(AI) in Healthcare Overview 1.2 Artificial Intelligence(AI) in Healthcare Market Overview: Global 1.3 Economic Overview: Finland 1.4 Artificial Intelligence(AI) in Healthcare Market Overview :Finland 1.5 Healthcare Overview: Finland 1.6 Budget of Tanzania Government for Public Insurance 1.7 Top Developments in Finland 15-17 2. Technologies and Future of AI 2.1 Technologies 2.2 Future of AI 18-23 3. Market Size and Forecasting 3.1 Finland Artificial Intelligence in Healthcare Market Size and Forecasts 4 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Table of Content CONTENT PG. NO. 3.2 Snapshot of Tanzania Artificial Intelligence in Healthcare Market Segmentation 3.2.1 Market Segmentation: By Component 3.2.2 Market Segmentation: By Application 3.2.3 Market Segmentation: By Technology 24-29 4. Market Dynamics 4.1 Market Growth Drivers 4.2 Market Growth Restraints 30-37 5. Competitive Landscape 5.1 Key Players in Finland Artificial Intelligence in Healthcare Market 38-43 6. Regulatory and Reimbursement Landscape 6.1 Regulatory Landscape in Finland 6.2 Reimbursement Scenario in Finland 6.3 Reimbursement Process 5 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Finland Artificial Intelligence (AI) in Healthcare Market Analysis 1. Market Overview
1.1 Artificial Intelligence (AI) in Healthcare Market Overview AI in healthcare refers to using machine learning, deep learning, natural language processing, and other AI techniques to analyze complex medical data ▪ This data can include patient records, medical images, sensors, and even wearables ▪ AI in healthcare includes imaging analysis tools for radiologists, virtual assistants for patient inquiries, robot-assisted surgery, and AI-driven drug discovery and development. ▪ Benefits of AI in healthcare are: Enhanced accuracy and efficiency in diagnosis • Improved prediction of health risks for preventive care • Development of personalized medicine for better treatment outcomes • Streamlined healthcare operations and reduced costs • Improved patient engagement and education • Illustrative Illustrative
1.2 Artificial Intelligence (AI) in Healthcare Market Overview: Global (1/2) 154 Bn Worldwide spending on AI-centric systems in 2023 Private Investment in AI Globally (In $Bn) 9.9 Mn Physicians, Nurses and Midwives shortfall globally by 2030 30 % Of world’s data stemming from healthcare industry by 2027 55% Profit increase in healthcare by 2035 due to AI according to Accenture 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 8 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
1.2 Artificial Intelligence (AI) in Healthcare Market Overview: Global (2/2) Finland Market ~$xx Bn Market Illustrative Illustrative 9 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
1.3 Economic Overview: Finland Population of Finland, (In Mn) GDP Growth of Finland (In %) 3.2 2.8 5.58 5.56 5.54 5.53 2.8 5.52 5.51 5.51 0.5 5.50 1.3 1.2 5.48 1.1 5.46 -1.0 -0.4 -2.4 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Population Split (2023) Finland is an aging country, as its median age is 42.8 years which is higher than global median age ▪ By Gender By Age Group Country's population’s global share is 0.07% and it is increasing at a rate of 0.09% Life expectancy of female is 85 years and for male it is 80 years Currently 87.2% of population is urban in Finland Top 3 largest cities are Helsinki, Espoo, Tampere ▪ Male 0-14 15% ▪ 25% Female 15-64 49% ▪ 51% 65+ 61% ▪ Illustrative Illustrative 10 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
1.4 Artificial Intelligence (AI) in Healthcare Market Overview: Finland (1/2) 84 AI applications in Finnish healthcare in 2022 65+ Population in the Finland (In %) 24 $5616 Current health expenditure per capita in 2021 23 23 22 22 22 21 21 24% Population of people aged 60 and older in 2023 20 20 49% Reported having at least one chronic condition in 2019 2014 2015 2016 2017 2018 2019 2020 2021 Illustrative Illustrative 2022 2023 11 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
1.5 Healthcare Overview: Finland Public Healthcare Private Healthcare Structure Structure › › Funding: Public healthcare in Finland is predominantly funded through general taxation Funding: Private healthcare is primarily patient-funded, though some costs may be covered by private insurance or employer benefits › Administration: The Ministry of Health oversees the system, with municipalities known as hospital districts managing services regionally › Administration: Private healthcare is delivered by independent providers operating outside the public system, including clinics, hospitals, and specialists › Services: Public healthcare covers hospital care, emergency services, maternity care, and specialist care, with affordable co-payments for some services › Services: Private providers offer a similar range of services as public ones but may have more advanced technology and a wider selection Access Access › Eligibility: All Finnish citizens, permanent residents, and some work visa holders are eligible for public healthcare › Wait times: Private healthcare typically offers shorter wait times, especially for specialist care › Cost: Many services, including hospital stays and emergency care, are free or subsidized › Costs: Private healthcare services are generally more expensive, with no co-payments, requiring full payment by the patient Illustrative Illustrative 12 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
1.6 Budget of Finland Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 In Billions Of Dollars Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% As % Of GDP National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 13 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
1.7 Top Developments in Finland Latest Deals in Finland Company Name Type Year Key Pointers Better, a digital health platform company, is working with Tietoevry to provide over 60 healthcare centers in Finland with the Lifecare clinical system based on the Better Platform and openEHR standard This has improved care efficiency and quality for almost 2 Mn citizens ▪ Partnership Feb, 2023 ▪ Openehr, a data-centric architecture standard, is being used as the basis for health data persistence infrastructure in Finland and other Nordic countries, enabling innovative digital health solutions ▪ Partnership Feb, 2023 Illustrative Illustrative 14 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Finland Artificial Intelligence (AI) in Healthcare Market Analysis 2. Technologies and Future of AI in healthcare
2.1 Technologies • Branch of Artificial Intelligence that uses an algorithm to examine previous data, current information and interactions Machine Learning • Deep learning is a subset of machine learning that uses multilayered neural networks and imitates human brain Deep Learning Natural Language Processing (NLP) • Process of understanding and interpreting text or language by a machine and can be used to interpret human language • Adjust responses based on analyzed data context, improving interactions and outputs in content management, information retrieval, user experiences, and decision-making systems Content-Aware Computing Illustrative Illustrative 16 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
2.2 Future of AI in healthcare AI-powered drug discovery with personalized medicine approaches: AI algorithms analyze vast molecular data sets to accelerate drug discovery and development, tailoring treatments to individual genetic profiles for personalized medicine ▪ AI-driven robotics for complex surgical procedures: Advanced AI-driven robotic systems assist surgeons in performing complex surgeries with greater precision, minimally invasive techniques, and improved patient outcomes ▪ AI-powered mental health chatbots and virtual therapists: AI mental health chatbots and virtual therapists provide accessible, real-time support and therapy for mental health issues, enhancing traditional care methods ▪ Wider adoption of AI-powered wearables for continuous health monitoring: AI-powered wearables are increasingly used for continuous health monitoring, tracking vital signs, and providing real-time health insights to users and healthcare providers ▪ Illustrative Illustrative 17 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Finland Artificial Intelligence (AI) in Healthcare Market Analysis 3. Market Size and Forecasting
3.1 Finland Artificial Intelligence (AI) in Healthcare Market Size and Forecasts Finland Artificial Intelligence (AI) in Healthcare Market Forecast, 2023-2030 2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F 2023 2024 2025 2026 2027 2028 2029 2030 Major Markets Patient ($Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Finland Patient Size ($Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 % of Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size ($Bn) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Finland Market Size ($Bn) 61 74 84 87 91 95 99 106 Illustrative Illustrative 19 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
3.2 Snapshot of Finland Artificial Intelligence (AI) in Healthcare Market Segmentation Component Applications Technology Hardware Diagnostics Machine Learning Software Drug Discovery and Development Natural Language Processing Services Robot Assisted Surgery Deep Learning Others Context-Aware Computing In this section you will get an understanding of the segmentations which will cover the Finland Artificial Intelligence (AI) in Healthcare Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Illustrative Illustrative 20 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
3.2.1 Market Segmentation: By Component Finland AI in Healthcare Market Share, By Component (2023) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Services Hardware ▪ ▪ Software Illustrative Illustrative 21 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
3.2.2 Market Segmentation: By Application Finland Artificial Intelligence (AI) in Healthcare Market Share, By Applications (2023) Others Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Patient Transportation Diagnostics ▪ ▪ Robot-Assisted Surgery Drug Discovery and Development Illustrative Illustrative 22 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
3.2.3 Market Segmentation: By Technology Finland Artificial Intelligence (AI) in Healthcare Market Share, By Technology (2023) Content-Aware Computing Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Machine Learning Deep Learning ▪ ▪ Healthcare at Home Natural Language Processing Illustrative Illustrative 23 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Finland Artificial Intelligence (AI) in Healthcare Market Analysis 4. Market Dynamics
4. Snapshot Of Market Growth Drivers And Restraints 4.1.1 4.1.2 4.1.3 Over 24% of Finland's population is 65 and older in 2023 Data solutions can cut Finland's healthcare costs by hundreds of millions of euros 84 AI applications in Finnish healthcare in 2022 4.2.1 High cost of implementing AI can be a restraint in healthcare market 4.2.2 Data privacy and security concern limits AI technology adoption and usage Illustrative Illustrative 25 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
4.1 Market Growth Drivers 4.1.1 New data-driven solutions can reduce Finland’s annual healthcare costs by hundreds of millions of euros, while also freeing up time for doctors and nurses to spend with patients Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Decrease healthcare expenditure In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 26 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
4.1 Market Growth Drivers 4.1.2 In 2022, Theseus identified 84 AI applications in Finnish healthcare, primarily aiding professionals, patient monitoring, and screening Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Increase In Demand In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 27 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
4.1 Market Growth Drivers 4.1.3 In 2023, over 24% of Finland's population is aged 65 and older, reflecting significant demographic aging Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Aging Population In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 28 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
4.2 Market Growth Restraints 4.2.1 Integrating AI technologies into healthcare entails substantial costs, necessitating significant investments in hardware, software, and training 4.2.2 Challenges in handling sensitive patient data create barriers, hindering trust and broader AI adoption in healthcare among providers and patients Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative Illustrative 29 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Finland Artificial Intelligence (AI) in Healthcare Market Analysis 5. Competitive Landscape
5.1 Key Players in Finland Artificial Intelligence (AI) in Healthcare Market Global Player Here is the list of top 10 companies which will cover in the final report ▪ Local Player 1 6 Each company will have slides for ▪ GE Healthcare Aidoc Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Illustrative Illustrative o o o o 2 7 Siemens Healthineers AiCure o o o 3 8 IBM Watson APIXIO, Inc o ▪ 4 9 Philips Healthcare Sonocare ▪ 10 5 NVIDIA HUS Helsinki 31 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
5.2.1 GE Healthcare (Continued) Offerings ▪ GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator ▪ It is a leader in global healthcare market, growing 4-6% per year Founded In: 1892 ➢ Medical Technology HQ: Chicago, US ➢ Healthcare Technology Management ▪ GE HealthCare’s business unit includes Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics ▪ GE uses AI to analyze sensor data from aircraft engines ▪ GE prioritizes using AI to solve real-world problems in its core businesses like aviation, energy, and healthcare. Type: Public Revenue: $19.06 Bn (Global) ➢ Clinical Network Solutions Website: gehealthcare.com ➢ Healthcare Financial Services Recent Activity / Press Coverage ▪ June 10, 2024 —GE HealthCare Announces Changes in Strategic Leadership and Key Segments to Better Serve Patients and Customers. ▪ It has named Roland Rott president and CEO of Imaging and Phil Rackliffe president and CEO of Ultrasound and IGT ▪ June 07, 2024 — GE HealthCare increases access to precision care tools, encouraging the continued adoption and practice of more personalized medicine around the world ▪ It has announced the development of its new MINItrace Magni, designed to be a small footprint, cost-effective cyclotron for reliable, in-house production of commercial PET tracers and radiometals – like Gallium-68 – through solid target technology ▪ May 22, 2024 — GE HealthCare Tops List for Third Year in a Row with Highest Number of AI-Enabled Medical Device Authorizations ▪ FDA’s list of AI-enabled device authorizations includes more than 850 devices; 72 are from GE HealthCare – more than any other medical technology company 32 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
5.2.1 GE Healthcare (Continued) Latest Deals in GE Healthcare Company Name Type Year Key Pointers Goal: Improve care protocols for CT, MR, and ultrasound systems in Mexico and Central America Focus: Enhance efficiency and effectiveness of healthcare delivery at Salud Digna's 200+ clinics Method: Utilize digital solutions to optimize clinical workflows and patient care Benefit: Streamline healthcare delivery for both clinicians and patients ▪ ▪ June 11, 2024 Acquisition ▪ ▪ Partners: GE HealthCare (medical technology) and Tampa General Hospital (academic health system) Action: Expanding long-term partnership Goal: Benefit patients and clinicians across Florida Method: Deploying GE HealthCare's Imaging and Ultrasound technology in TGH Imaging's outpatient facilities ▪ ▪ May 30, 2024 Partnership ▪ ▪ Illustrative Illustrative 33 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
5.2.1 GE Healthcare (Continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2023 ▪ 1 2 3 4 Illustrative Illustrative 34 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
5.2.2 Company 2 Offerings Founded In: HQ: Type: Revenue: Website: Recent Activity / Press Coverage Illustrative Illustrative 35 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
5.2.2 Company 2 (Continued) Latest Deals in CompanyName Company Name Type Year Key Pointers Illustrative Illustrative 36 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
5.2.2 Company 2 (Continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2023 ▪ 1 2 3 4 Illustrative Illustrative 37 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Finland Artificial Intelligence (AI) in Healthcare Market Analysis 6. Regulatory and Reimbursement Landscape
6.1 Regulatory Landscape in Finland Regulatory Authorities With Jurisdiction Over Drugs, Biologicals, And Medical Devices In Finland 1. Medicines Regulation Finnish Medicines Agency (Fimea): Fimea, the central authority for regulating human and veterinary drugs in Finland, evaluates and approves new medications for market use. It monitors these drugs throughout their lifecycle to ensure safety and effectiveness and maintains a secure supply chain to prevent shortages and ensure consistent quality 2. Medical Devices Regulation Finnish Safety and Chemicals Agency (Tukes): Tukes is tasked with ensuring the safety and quality of medical devices available in Finland. It grants marketing authorization to medical devices, ensuring they meet stringent safety and efficacy standards before they can be sold. Tukes also conducts ongoing market surveillance to monitor the performance and safety of medical devices already in use. This continuous oversight helps in identifying and mitigating any potential risks associated with medical devices 3. Healthcare Professionals and Facilities Regulation National Supervisory Authority for Welfare and Health (Valvira): Valvira is responsible for regulating healthcare professionals, ensuring they possess the necessary qualifications and adhere to high standards of practice. It oversees healthcare facilities to ensure they provide safe, high-quality care to patients. Valvira also works to maintain and improve the overall quality and safety of healthcare services in Finland, ensuring compliance with national healthcare standards and guidelines Illustrative Illustrative 39 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
6.2 Reimbursement Scenario in CountryName Regulatory Framework For The Authorization, Pricing, And Reimbursement Of Drugs Key Legislation The key legislations for the drug industry in Finland are Health Insurance Act (2004), Act on the Dental and Pharmaceutical Benefits Agency (TLV) (2009:726), Medicinal Products Act (2015:315), Regulations Implementing EU MDR and IVDR (2017) Authorization Health Insurance Act (2004): Governs the reimbursement of healthcare services, including AI technologies, by defining eligible services, criteria for reimbursement, and application processes ▪ Act on the Dental and Pharmaceutical Benefits Agency (TLV) (2009:726):Establishes the TLV, which evaluates the ▪ benefits and cost-effectiveness of AI applications and sets reimbursement levels and guidelines Medicinal Products Act (2015:315): Focuses on the safety and quality of pharmaceuticals and AI-based medical devices, ▪ influencing reimbursement by ensuring only effective technologies are considered Regulations Implementing EU MDR and IVDR (2017): Implements EU standards for AI-based medical devices, ensuring ▪ compliance with safety and performance requirements as a prerequisite for reimbursement Illustrative Illustrative 40 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
6.2 Reimbursement Scenario in Finland (Continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) 100% 100% 100% 100% 100% 44.0% Government Expenditure xx 46.0% xx 47.7% xx xx xx 51.0% 51.8% Public Healthcare Coverage Private Health Insurance Out of Pocket 38.9% 37.1% 35.6% 31.5% 32.5% Private Coverage Other NA NA 2019 2020 2021 2022 2023 2017 2018 2019 2020 2021 2022 2023 Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities 6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy) 14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy) Reimbursement Market Trends ▪ Shift towards value-based care has been a significant trend in Finland healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs ▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative Illustrative 41 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
6.3 Reimbursement Process The reimbursement process in Finland healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient ▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided ▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud ▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule ▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost of the service, such as deductibles, co-payments, or co-insurance In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 42 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
6.3 Reimbursement Process (Continued) The reimbursement process in Finland healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: MoH Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient ▪ Market Authorization Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided ▪ Private Payers Public Payers Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud ▪ Health Technology Assessment Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule ▪ 1 2 3 Coding Coverage Payment Coding depends on availability code while coverage and payment process decisions are made through an HTA. Illustrative Illustrative 43 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
A division of
Life-sciences Market Research Reports you can trust We maintain an extensive database comprising over 30,000 syndicated market research reports within the pharmaceuticals and healthcare sector, offering a global, regional, and country-level perspective. Our services also include the provision of customized research reports, meticulously tailored to align with your specific requirements. www.insights10.com www.insights10.com
Pharma (Diseases & Drugs) Digital Health Market Research Reports across various categories in healthcare OTC & Medical Devices Nutraceuticals At Insights10, our extensive report library spans a diverse range of categories within the field of life sciences. Clinical Trials Healthcare Services Rare Diseases www.insights10.com www.insights10.com
Global Coverage Europe • UK • Germany • France • Italy • Spain • Russia • Netherlands • Sweden • Romania • Switzerland • Poland • Austria • Ireland • Norway • Denmark • Belgium • Portugal • Ukraine • Bulgaria • Finland APAC • India • China • South Korea • Japan • Australia • Indonesia • Hong Kong • New Zealand • Philippines • Singapore • Malaysia • Thailand • Vietnam North America • US • Canada Africa • Egypt • Kenya • South Africa • Algeria • Nigeria • Libya • Tanzania • Morocco Middle East • UAE • Saudi Arabia • Turkey • Lebanon • Kuwait • Qatar Latin America • Brazil • Argentina • Mexico • Ecuador • Venezuela • Senegal Click on the country to see the reports available
What do our reports cover? Market Overview Competitive Landscape 1 6 Growth Drivers & Growth Restraints 2 7 Policy & Regulatory Landscape Epidemiology & Disease type 3 8 Reimbursement Scenario Market Size & Forecast Recent Developments 4 9 Market Segmentation Factors Driving Future Growth 5 10
Our Research Process 01 02 03 04 05 06 Define precise research questions Gather data through secondary research Validate data through primary research interviews Forecast market size and segment analysis Extract key insights from the research findings Compile & present a comprehensive analytical report
Data Triangulation & Data Validation Top Down Approach Find final Examine the total healthcare expenditure in the targeted disease or service domain. market size Assess the proportion of spending allocated to the specific product or treatment category. Predict future market growth or decline based on key market trends & dynamics Predict future market growth or decline based on key market trends & dynamics Analyze product or treatment pricing and reimbursement strategies Find final market size Evaluate consumer or patient demographics and numbers Bottom Up Approach